The Blood Group Typing Market is becoming increasingly important as healthcare systems strengthen transfusion safety and modernize blood-bank infrastructure. The market is projected to rise from USD 2.61 billion in 2026 to USD 5.31 billion by 2035, reflecting an 8.2% CAGR.

Growing surgical volumes are creating a consistent need for accurate blood typing and compatibility testing. Blood-group analysis is also required in organ transplantation and supports the management of patients who receive frequent transfusions. These clinical requirements provide a stable foundation for demand across hospitals and blood banks.

Automation is transforming laboratory workflows through automated analyzers, gel-card systems, solid-phase technologies, and digital image interpretation. Consumables remain the largest product category, while services are expected to grow at the fastest rate as hospitals increasingly rely on specialized laboratories for complex testing.

North America held about 35.5% of the global market in 2025, followed by Europe at approximately 28%. Asia-Pacific represents a major expansion opportunity, with a projected 9.4% CAGR through 2035 as governments and healthcare providers invest in blood-donation programs, testing capacity, and modern transfusion infrastructure.

The long-term outlook includes greater adoption of precision transfusion practices. Extended antigen genotyping, AI-supported antibody identification, portable blood-typing systems, and sustainable reagent technologies are expected to broaden the capabilities of blood services and improve testing efficiency.

Gain valuable insights through comprehensive industry analysis:

Micro Guide Catheters Market Trends

RNAi Technology Market Growth

Electrical Stimulation Devices Market Demand

Psychotropic Drugs Market Volume

Hepatitis B Treatment Market Forecast